Holdings A/S Novo - Jun 17, 2021 Form 3 Insider Report for Cyteir Therapeutics, Inc. (CYT)

Role: 10%+ Owner
Signature: /s/ Peter Haahr, Chief Financial Officer of Novo Holdings A/S
Stock symbol: CYT
Transactions as of: Jun 17, 2021
Transactions value $: $0
Form type: 3
Date filed: 6/17/2021, 09:43 PM
Previous filing: Jun 16, 2021
Next filing: Jun 22, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CYT	SERIES B CONVERTIBLE PREFERRED STOCK							Jun 17, 2021	COMMON STOCK	4.11M		Direct	F1
holding	CYT	SERIES C CONVERTIBLE PREFERRED STOCK							Jun 17, 2021	COMMON STOCK	456K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock will convert automatically into shares of common stock based on a conversion ratio of 1 share of preferred stock for 0.2934 shares of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date. The securities shown in Column 3 give effect to the conversion ratio.

Content

Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock will convert automatically into shares of common stock based on a conversion ratio of 1 share of preferred stock for 0.2934 shares of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date. The securities shown in Column 3 give effect to the conversion ratio.